128 related articles for article (PubMed ID: 16557278)
21. VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma.
Talvensaari-Mattila A; Soini Y; Santala M
Tumour Biol; 2005; 26(2):81-7. PubMed ID: 15867479
[TBL] [Abstract][Full Text] [Related]
22. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
23. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways.
Santos SC; Dias S
Blood; 2004 May; 103(10):3883-9. PubMed ID: 14726393
[TBL] [Abstract][Full Text] [Related]
24. Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
Inan S; Vatansever S; Celik-Ozenci C; Sanci M; Dicle N; Demir R
Histol Histopathol; 2006 Oct; 21(10):1055-64. PubMed ID: 16835828
[TBL] [Abstract][Full Text] [Related]
25. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.
Giatromanolaki A; Koukourakis MI; Sivridis E; Thorpe PE; Brekken RA; Konstantinos S; Fountzilas G; Gatter KC; Harris AL
Clin Exp Metastasis; 2000; 18(4):313-9. PubMed ID: 11448062
[TBL] [Abstract][Full Text] [Related]
26. Ovarian steroids in endometrial angiogenesis.
Perrot-Applanat M; Ancelin M; Buteau-Lozano H; Meduri G; Bausero P
Steroids; 2000; 65(10-11):599-603. PubMed ID: 11108865
[TBL] [Abstract][Full Text] [Related]
27. Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells.
Olszewska-Pazdrak B; Hein TW; Olszewska P; Carney DH
Am J Physiol Cell Physiol; 2009 May; 296(5):C1162-70. PubMed ID: 19244479
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression.
Giatromanolaki A; Fiska A; Pitsiava D; Kartalis G; Koukourakis MI; Sivridis E
In Vivo; 2009; 23(5):699-703. PubMed ID: 19779103
[TBL] [Abstract][Full Text] [Related]
29. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
30. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues.
Pallares J; Rojo F; Iriarte J; Morote J; Armadans LI; de Torres I
Histol Histopathol; 2006 Aug; 21(8):857-65. PubMed ID: 16691538
[TBL] [Abstract][Full Text] [Related]
31. Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.
Kwak HJ; Park MJ; Park CM; Moon SI; Yoo DH; Lee HC; Lee SH; Kim MS; Lee HW; Shin WS; Park IC; Rhee CH; Hong SI
Int J Cancer; 2006 Jun; 118(11):2711-20. PubMed ID: 16388516
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis and endometrial cancer.
Sivridis E
Anticancer Res; 2001; 21(6B):4383-8. PubMed ID: 11908694
[TBL] [Abstract][Full Text] [Related]
34. Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.
Calvani M; Trisciuoglio D; Bergamaschi C; Shoemaker RH; Melillo G
Cancer Res; 2008 Jan; 68(1):285-91. PubMed ID: 18172321
[TBL] [Abstract][Full Text] [Related]
35. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis.
Kuwabara M; Kakinuma Y; Ando M; Katare RG; Yamasaki F; Doi Y; Sato T
J Physiol Sci; 2006 Feb; 56(1):95-101. PubMed ID: 16779917
[TBL] [Abstract][Full Text] [Related]
37. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1alpha levels in human endometrial and endothelial cells.
Yoshie M; Miyajima E; Kyo S; Tamura K
Endocrinology; 2009 May; 150(5):2413-8. PubMed ID: 19179443
[TBL] [Abstract][Full Text] [Related]
38. Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy.
del Puerto-Nevado L; Rojo F; Zazo S; Caramés C; Rubio G; Vega R; Chamizo C; Casado V; Martínez-Useros J; Rincón R; Rodríguez-Remírez M; Borrero-Palacios A; Cristóbal I; Madoz-Gúrpide J; Aguilera O; García-Foncillas J
Br J Cancer; 2014 May; 110(11):2700-7. PubMed ID: 24786599
[TBL] [Abstract][Full Text] [Related]
39. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
[TBL] [Abstract][Full Text] [Related]
40. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.
Yoshinaga K; Ito K; Moriya T; Nagase S; Takano T; Niikura H; Yaegashi N; Sato Y
Cancer Sci; 2008 May; 99(5):914-9. PubMed ID: 18325046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
